MedPath

Parkinson's Foundation Quality Improvement Initiative

Completed
Conditions
Parkinson's Disease
Registration Number
NCT01629043
Lead Sponsor
National Parkinson Foundation
Brief Summary

In a recent study it was found that neurologist care for Parkinson's provides a 20% reduction in nursing home placement, hip fracture, and death (Willis 2011). However, as the authors recognized, the investigators don't know what it is about expert care that delivers this benefit. The Parkinson's Foundation's Quality Improvement Initiative was designed to identify the components of great care that yield great outcomes. By capturing demographics, clinical interventions and outcomes over time from multiple centers across the U.S, Canada and internationally, the best care practices from different clinics and different healthcare systems will be analyzed.

Detailed Description

In a recent study it was found that neurologist care for Parkinson's provides a 20% reduction in nursing home placement, hip fracture, and death (Willis 2011). However, as the authors recognized, we don't know what it is about expert care that delivers this benefit. The Parkinson's Foundation's Quality Improvement Initiative was designed to identify the components of great care that yield great outcomes. By capturing demographics, clinical interventions and outcomes over time from multiple centers across the U.S, Canada and internationally, the best care practices for improving care, survival, and quality of life from different clinics and different healthcare systems will be analyzed.

The Parkinson's Foundation's QII contains demographic data, information about the patient's Parkinson's disease and other comorbid illness, patient assessments of Parkinson's related physical, emotional and cognitive disability and clinician tests of mobility, memory and cognition. It also includes data on the burden of the disease on caregivers. The tests and questionnaire instruments are currently in regular use in clinical practice. The intent of the registry is not to evaluate the instruments themselves but to collect essential data from previously validated tools.

Registry data will be used to study the relationship between treatment and clinical symptoms of patients with Parkinson's. It will also be used to evaluate and improve care of patients at participating Centers. Through presentation and publication of results, it is hoped that improvement will become more widespread. Important benefits provided by such a Registry may ultimately be to:

* Determine the long term effects of Parkinson's disease and related conditions on quality of life;

* Generate regular reports for Centers including descriptions of their Parkinson's patient populations, treatments utilized at the Center and trends in their patients' outcomes over time;

* Describe differences in current practice across Centers in the care of Parkinson's patients;

* Identify patients who may be candidates for participation in trials of new medications;

* Facilitate or initiate quality improvement efforts intended to enhance survival and/or improve quality of life for Parkinson's disease patients; and

* Publish and otherwise disseminate findings related to most effective treatments to encourage rapid adoption of "best practices."

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13000
Inclusion Criteria
  • Patients diagnosed with idiopathic Parkinson's disease receiving medical care for the diagnosis of idiopathic Parkinson's disease at any of the participating Centers.
Exclusion Criteria

Patients who are not willing or won't be able to give written informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (24)

Johns Hopkins Parkinson's Disease and Movement Disorder Center

🇺🇸

Baltimore, Maryland, United States

Northwestern University Parkinson's Disease and Movement Disorders Center

🇺🇸

Chicago, Illinois, United States

Beth Israel Deaconess Medical Center Parkinson's Disease Movement Disorder Center

🇺🇸

Boston, Massachusetts, United States

University of South Florida

🇺🇸

Tampa, Florida, United States

Baylor College of Medicine Parkinson Disease Center and Movement Disorders Clinic

🇺🇸

Houston, Texas, United States

Barrow Neurological Institute - Muhammad Ali Parkinson Center

🇺🇸

Phoenix, Arizona, United States

University of Miami Parkinson's Disease and Movement Disorders Center

🇺🇸

Miami, Florida, United States

Parkinson's Institute and Clinical Center

🇺🇸

Sunnyvale, California, United States

University of Florida Parkinson's Disease and Movement Disorders Center

🇺🇸

Gainesville, Florida, United States

Augusta University

🇺🇸

Augusta, Georgia, United States

University of Kansas Medical Center Parkinson's Disease and Movement Disorder Center

🇺🇸

Kansas City, Kansas, United States

NYU Langone Medical Center

🇺🇸

New York, New York, United States

Oregon Health and Science University Parkinson Center

🇺🇸

Portland, Oregon, United States

Struthers Parkinson Center

🇺🇸

Golden Valley, Minnesota, United States

Mount Sinai School of Medicine Parkinson and movement Disorders Center

🇺🇸

New York, New York, United States

University of Pennsylvania Parkinson's Disease and Movement Disorder Center

🇺🇸

Philadelphia, Pennsylvania, United States

The Vanderbilt Parkinson Disease Center

🇺🇸

Nashville, Tennessee, United States

McGill University Health Centre

🇨🇦

Montreal, Quebec, Canada

Toronto Western Hospital Movement Disorders Center

🇨🇦

Toronto, Ontario, Canada

University of Alberta

🇨🇦

Edmonton, Alberta, Canada

Centre for Movement Disorders

🇨🇦

Markham, Ontario, Canada

Tel Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Parkinson Center Nijmegen at Radboud University Nijmegen Medical Center

🇳🇱

Nijmegen, Netherlands

Georgetown University Hospital

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath